AMY MOSMAN: Open Payments
NPI 1255756961 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,027 in 46 payments from 10 companies in 2025. Trend: 2023 $770 · 2024 $6,284 · 2025 $14,027
Speaker / faculty: $7,600Travel & lodging: $3,814Food & beverage: $2,594Education: $19
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 35 | $13,248 |
| Madrigal Pharmaceuticals | 1 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $123 |
| GlaxoSmithKline, LLC. | 2 | $122 |
| Corcept Therapeutics | 1 | $106 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $92 |
| ABBVIE INC. | 1 | $91 |
| Novo Nordisk Inc | 2 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 1 | $19 |
Products named: XPHOZAH 30 MG, REZDIFFRA, Kerendia, BLUJEPA, Korlym, VRAYLAR, IBSRELA, JARDIANCE.
Industry payments across MO — which companies pay providers there.
